The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe
Launched by EUTHYROID · Jan 29, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called EUthyroid2, is focused on addressing iodine deficiency, which can lead to health problems if not managed properly. The trial is taking place in several countries, including the UK, Germany, Slovenia, Cyprus, Bangladesh, and Pakistan. The goal is to raise awareness about the risks of iodine deficiency in schools and educational settings. Researchers will implement specific measures in each country to educate students and teachers, and they will gather information through surveys and interviews to evaluate how effective these measures are.
Anyone aged between 4 and 20 who can understand the study information and provide informed consent can participate. There are no specific exclusions, so if you meet the age requirement and can communicate effectively, you may be eligible. Participants can expect to be involved in surveys and discussions that will help researchers understand the impact of the educational efforts on awareness of iodine deficiency. This study is an important step towards eliminating iodine-related health issues in Europe and beyond.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • sufficient language skills to understand the study information, informed consent
- Exclusion Criteria:
- • none
About Euthyroid
Euthyroid is a clinical trial sponsor dedicated to advancing research in thyroid health and related metabolic disorders. With a focus on innovative therapeutic solutions, Euthyroid collaborates with leading healthcare professionals and research institutions to design and conduct rigorous clinical studies aimed at improving patient outcomes. The organization is committed to ethical standards, patient safety, and the integration of cutting-edge science in the development of new treatments, ultimately striving to enhance the quality of life for individuals affected by thyroid conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ljubljana, , Slovenia
Greifswald, , Germany
Limassol, , Cyprus
Dhaka, , Bangladesh
Peshawar, Khyber Pakhtunkhwa, Pakistan
Guildford, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported